OpenLB
Open Library of Bioscience
Advanced Search
Annals of translational medicine
Oct 25, 2023;11 (11): 395.

Mortality reduction in severe community-acquired pneumonia: key findings from a large randomized controlled trial and their clinical implications.

Ovidiu Vornicu, Emily Perriens, Sydney Blackman, Elina Smoos, Christophe Al Sammour, Ilann Oueslati, Alexis Philippot, David Vidal Bankier, Charbel Haddad, Maha Bendoumou, Tom François, Isabelle Michaux, Anne-Sophie Dincq, Patrick Evrard, Pierre Bulpa, Patrick M Honore
Author Information
  1. Ovidiu Vornicu: ICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
  2. Emily Perriens: ULB University Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
  3. Sydney Blackman: ULB University Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
  4. Elina Smoos: ULB University, Brussels, Belgium.
  5. Christophe Al Sammour: ULB University, Brussels, Belgium.
  6. Ilann Oueslati: ULB University, Brussels, Belgium.
  7. Alexis Philippot: ULB University, Brussels, Belgium.
  8. David Vidal Bankier: ULB University, Brussels, Belgium.
  9. Charbel Haddad: ULB University, Brussels, Belgium.
  10. Maha Bendoumou: ULB University, Brussels, Belgium.
  11. Tom François: ULB University, Brussels, Belgium.
  12. Isabelle Michaux: ICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
  13. Anne-Sophie Dincq: ICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
  14. Patrick Evrard: ICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
  15. Pierre Bulpa: ICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
  16. Patrick M Honore: ICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
PMID: 37970598 DOI: 10.21037/atm-23-1719

Abstract

No abstract text available.

Keywords

28 days mortality Severe community-acquired pneumonia (severe CAP) hydrocortisone implications for clinicians septic shock excluded

References

  1. N Engl J Med. 2021 Feb 25;384(8):693-704 [PMID: 32678530]
  2. PLoS One. 2014 Jun 09;9(6):e99518 [PMID: 24910975]
  3. Intensive Care Med. 2011 Sep;37(9):1553-4 [PMID: 21688102]
  4. N Engl J Med. 2023 May 25;388(21):1931-1941 [PMID: 36942789]
  5. Intensive Care Med. 2023 Jun;49(6):615-632 [PMID: 37012484]
  6. Intensive Care Med. 2023 Jun;49(6):656-658 [PMID: 37100928]
  7. Curr Opin Infect Dis. 2021 Apr 1;34(2):169-174 [PMID: 33394726]
  8. Intensive Care Med. 2022 Aug;48(8):1009-1023 [PMID: 35723686]
  9. Chest. 2007 Apr;131(4):954-63 [PMID: 17426195]
  10. Popul Health Metr. 2017 Aug 30;15(1):32 [PMID: 28854976]
  11. Am J Respir Crit Care Med. 2005 Feb 1;171(3):242-8 [PMID: 15557131]
  12. Wien Med Wochenschr. 2023 Apr;173(5-6):140-151 [PMID: 36624180]
  13. Eur Respir Rev. 2021 Feb 9;30(159): [PMID: 33568526]
  14. Heart Vessels. 1997;12(2):84-91 [PMID: 9403312]
  15. N Engl J Med. 2018 Mar 01;378(9):809-818 [PMID: 29490185]
  16. JAMA. 2002 Aug 21;288(7):862-71 [PMID: 12186604]
  17. Am J Respir Crit Care Med. 2005 Sep 15;172(6):781; author reply 782-3 [PMID: 16148196]
  18. Medicine (Baltimore). 2019 Mar;98(13):e14636 [PMID: 30921179]
Editorial Comment

Word Cloud

Created with Highcharts 10.0.0severecommunity-acquiredimplicationsMortalityreductionpneumonia:keyfindingslargerandomizedcontrolledtrialclinical28daysmortalitySeverepneumoniaCAPhydrocortisoneclinicianssepticshockexcluded

Similar Articles

Cited By

No available data.